Comparative Efficacy of Spironolactone, Eplerenone, Nebivolol and Moxonidine in Patients With Resistant Arterial Hypertension. UJC 2019, 25 (6), 65-71. https://doi.org/10.31928/1608-635X-2018.6.6571.